Woodline Partners’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-600,403
Closed -$4.72M 795
2022
Q4
$4.72M Sell
600,403
-953,679
-61% -$6.7M 0.06% 327
2022
Q3
$9.56M Sell
1,554,082
-87,794
-5% -$529K 0.13% 206
2022
Q2
$8.7M Sell
1,641,876
-574,186
-26% -$3.47M 0.13% 192
2022
Q1
$14.5M Buy
2,216,062
+957,661
+76% +$8.53M 0.24% 127
2021
Q4
$20.6M Buy
+1,258,401
New +$26.2M 0.3% 92
2020
Q4
Sell
-415,895
Closed -$19.4M 276
2020
Q3
$19.4M Sell
415,895
-528,630
-56% -$18.2M 0.63% 45
2020
Q2
$34.1M Buy
944,525
+500,191
+113% +$18.4M 1.35% 23
2020
Q1
$15.8M Buy
444,334
+171,216
+63% +$7.01M 1.13% 25
2019
Q4
$12.4M Buy
+273,118
New +$9.92M 0.51% 62

Other funds holding ZYME

Woodline Partners's ZYME Position: Q1 2023 in Review

Woodline Partners sold out of Zymeworks (ZYME) in Q1 2023, closing a stake of 600,403 shares — an estimated $4.72M sold.

Woodline Partners first reported a position in ZYME in Q4 2019 and held it in 9 quarters. The position peaked at $34.1M in Q2 2020. 115 funds tracked by Wall St. Rank hold ZYME as of Q1 2023.

  • Woodline Partners reported no remaining Zymeworks position as of Q1 2023 after selling out during the quarter.
  • Woodline Partners sold 600,403 Zymeworks shares in Q1 2023, an estimated $4.72M.
  • Woodline Partners first reported a position in Zymeworks in Q4 2019 and held it in 9 quarters.
  • Woodline Partners's Zymeworks position peaked at $34.1M in Q2 2020.
  • 115 funds tracked by Wall St. Rank held Zymeworks as of Q1 2023.

Based on Woodline Partners's 13F filing for Q1 2023, filed 15 May 2023.